PDPN and cancer: This study suggests that cancer cell adhesion to the extracellular matrix (ECM) is linked to mutations in the atypical cadherin and tumor suppressor FAT3 in a subset of patients, as well as to a mesenchymal–mesothelial phenotype involving the upregulation of calretinin and podoplanin.